Kyverna Therapeutics, Inc.
What this means
- Net loss in 2025Net loss of $161M for the year (2024: −$127M).
What to do next
- How to check a US company before you sign a contractguide
- How to read an 8-K: what customers and creditors should checkguide
Guides from the Companies Daily newsroom, picked for what the register shows.
Financials from XBRL
| Calendar-year frame | 2025 | 2024 |
|---|---|---|
| Net income (loss) | −$161M | −$127M |
| Total assets | $294M | $305M |
| Total liabilities | $61.6M | $38.1M |
| Stockholders’ equity | $232M | $267M |
| Cash and equivalents | $124M | $96.6M |
From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.
- Name as filed
- Kyverna Therapeutics, Inc.
Formerly: Kyverna Therapeutics, Inc. - CIK
- 0001994702
- Tickers
- KYTX
- Kind of filer
- SEC-reporting company
Emerging growth company - Status
- Filing with the SEC
- State of incorporation
- Delaware
- Business address
- Emeryville, California
- Industry (SIC)
- 2836 · Biological products, (no diagnostic substances)
Industry: D · Manufacturing → - Fiscal year ends
- December 31
- Last annual report
- 10-K for the period ended Dec 31, 2025
- Last quarterly report
- 10-Q for the quarter ended Sep 30, 2026
- Bankruptcy reported
- Not in our data
- Last edition event
- Nov 12, 2026
Filing history
Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.
- Form 10-Q · filed Nov 12, 2026 · filing · edition of Nov 12, 2026
- Form 8-K · items 2.02, 9.01 · filed Nov 12, 2026 · filing · edition of Nov 12, 2026
- Form 8-K · items 2.02, 9.01 · filed Aug 11, 2026 · filing
- Form 10-Q · filed Aug 11, 2026 · filing
- Form 8-K · items 5.02, 8.01, 9.01 · filed May 18, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed May 12, 2026 · filing
- Form 10-Q · filed May 12, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed Mar 26, 2026 · filing
- Form 10-K · filed Mar 26, 2026 · filing
- Form 8-K · items 5.02, 8.01, 9.01 · filed Feb 24, 2026 · filing
- Form 8-K · items 5.02, 8.01, 9.01 · filed Feb 3, 2026 · filing
- Form 8-K · items 2.02, 5.02, 9.01 · filed Jan 12, 2026 · filing
- Form 8-K · items 2.02, 5.02, 9.01 · filed Jan 12, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed Nov 12, 2025 · filing
- Form 10-Q · filed Nov 12, 2025 · filing
- Form 8-K · items 5.02, 9.01 · filed Sep 25, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed Aug 12, 2025 · filing
- Form 10-Q · filed Aug 12, 2025 · filing
- Form 8-K · items 5.02, 8.01, 9.01 · filed Jun 30, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed May 13, 2025 · filing
- Form 10-Q · filed May 13, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed Mar 27, 2025 · filing
- Form 10-K · filed Mar 27, 2025 · filing
- Form 8-K · items 5.02, 9.01 · filed Nov 26, 2024 · filing
- Form 8-K · items 2.02, 5.02, 9.01 · filed Nov 13, 2024 · filing
- Form 8-K · items 2.02, 5.02, 9.01 · filed Nov 13, 2024 · filing
- Form 10-Q · filed Nov 13, 2024 · filing
- Form 8-K · items 5.02, 8.01, 9.01 · filed Oct 21, 2024 · filing
- Form 8-K · items 5.02, 8.01, 9.01 · filed Sep 16, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed Aug 12, 2024 · filing
- Form 10-Q · filed Aug 12, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed May 14, 2024 · filing
- Form 10-Q · filed May 14, 2024 · filing
- Form SC 13D · filed May 3, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed Mar 26, 2024 · filing
- Form 10-K · filed Mar 26, 2024 · filing
- Form 424B4 · filed Feb 8, 2024 · filing
- Form S-1 · filed Jan 16, 2024 · filing
- Form D · items 06b · filed Nov 7, 2023 · filing